Press release
Canavan Disease Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments
Canavan disease is a rare inherited disorder that damages the ability of nerve cells (neurons) in the brain to send and receive messages. Canavan disease is one of a group of genetic disorders, known as leukodystrophies. Leukodystrophies disrupt the growth or maintenance of the myelin sheath, which is the covering that protects nerves and promotes the efficient transmission of nerve impulses. Neonatal/infantile Canavan disease is the most common and most severe form of the condition.Read market summary report : http://bit.ly/2pdk71h
Affected infants appear normal for the first few months of life. By the age of three to five months, problems with the infant development become noticeable. These infants usually do not develop motor skills such as turning over, controlling head movement, and sitting without support. Other common features of Canavan disease include weak muscle tone (hypotonia), an unusually large head size (macrocephaly), and irritability. Feeding and swallowing difficulties, seizures, and sleep disturbances may also develop.
The mild/juvenile form of Canavan disease is less common. Affected individuals have mildly delayed development of speech and motor skills starting in childhood. These delays may be so mild and nonspecific that they are never recognized as being caused by Canavan disease. The drug candidates in the pipeline of Canavan disease include, but are not limited to, OPC 1 and ALD 101.
Request sample report : http://bit.ly/2pd3KBx
The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licencing, grants, technology and others.
Some of the companies having drugs in the Canavan disease pipeline include Turing Pharmaceuticals AG and Pfizer Inc.
Access Summary of Report :https://www.psmarketresearch.com/market-analysis/canavan-disease-therapeutics-pipeline-analysis
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-Free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Canavan Disease Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments here
News-ID: 979910 • Views: …
More Releases from P&S Market Research
Smart Cities Market Size, Revenue, Technology, Competitive Analysis, Growth Driv …
The global smart cities market is growing at a CAGR above 20% during 2018 - 2023 and will reach $2578.0 billion by 2023. Due to significant growth in automation technologies such as internet of things (IoT) and adoption of cloud based technologies, the global smart cities market is gaining huge traction. In addition, effective city asset management for public welfare, substantial operational cost savings, and automated public data generation applications…
Global Sports Food Market Expected to Witness 9.2% CAGR During 2016 – 2022
The global sports food market is expected to grow at a CAGR of 9.2% in terms of value during 2016 - 2022. Among the various types, the energy bars segment accounted for the largest share (71.5%) in the global sports food market in 2015.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/sports-food-market/report-sample
The manufacturers are trying to bring about products with the best blend of taste and healthy ingredients. They have started to…
Sports Nutrition Market by Type, Distribution Channel, Region, Growth and Demand …
The global sports nutrition market is expected to grow at a CAGR of 8.4% in terms of value during 2016 - 2022. Among the various types, the sports drinks segment accounted for largest share (61.4%) in the global sports nutrition market in 2015.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/sports-nutrition-market/report-sample
The increasing health concerns, such as obesity and awareness of physical appearances among all consumers groups is driving the demand for sports…
Orthopedic Trauma Devices Market Supply Chain Trends Mapping the Latest Technolo …
The global orthopedic trauma devices market is growing due to the increasing frequency of fractures, along with the growth of aging population. The advantageous features posed by orthopedic trauma devices, such as internal and external fixators to set a fracture, and in repositioning of bone fragments into their normal alignment are also driving the growth of the market worldwide. Furthermore, the internal fixators have reduced the hospital stays, reduced the…
More Releases for Canavan
Canavan Disease Treatment Market: Current trends/opportunities/challenges
Global Canavan Disease Treatment Market: Overview
Canavan-van Bogaert-Bertrand or Canavan disease is a rare and fetal genetic condition. It is an autosomal recessive condition that causes damage to cells of nervous system in the brain. It is a common progressive cerebral disease in newborns. Canavan disease is caused by the lack of aminoacylase 2 enzyme. Canavan disease is one of the disease condition in leukodystrophies. Leukodystrophies is a set of genetic…
Canavan Disease Professional Survey and Pipeline Review H1 2017
Canavan Disease
Overview
Canavan disease is a gene-linked neurological disorder in which the brain degenerates into spongy tissue riddled with microscopic fluid-filled spaces. Cause includes a mutation in the gene which directs the production of the enzyme aspartoacylase (ASPA) allows the buildup of N-acetylaspartic acid (NAA) in the brain. The buildup of NAA causes damage to myelin. Symptoms include lack of motor development, feeding difficulties, abnormal muscle tone, and an…
Canavan Disease Therapeutics Market Size, Share and Forecast till 2022
In this report, the EMEA Canavan Disease Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you.
Request Sample…
EMEA (Europe, Middle East and Africa) Canavan Disease Therapeutics Market Report …
In this report, the EMEA Canavan Disease Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you.
Request Sample…
Global Canavan Disease Therapeutics Market Outlook & Deep Study of Top Consumers …
Market Research Hub (MRH) has recently added a new report to its vast online database. This research study is titled as “Global Canavan Disease Therapeutics Market” 2017 which presents an in-depth study about the production, consumption, market volume, revenue (million USD) and market share across different geographical regions.
Request For Free Sample - https://www.marketresearchhub.com/enquiry.php?type=S&repid=1421682
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million…
Canavan Disease Pharmaceutical and Healthcare Analysis Information
Pune, India, 18th December 2017: WiseGuyReports announced addition of new report, titled “Canavan Disease - Pipeline Review, H2 2017”.
Summary
Canavan disease is a gene-linked neurological disorder in which the brain degenerates into spongy tissue riddled with microscopic fluid-filled spaces. Cause includes a mutation in the gene which directs the production of the enzyme aspartoacylase (ASPA) allows the buildup of N-acetylaspartic acid (NAA) in the brain. The buildup of NAA causes damage…
